Prof Robert Nicholson
Career Profile And Research Interest
Robert Nicholson is currently the Professor of Cancer Pharmacology at the School of Pharmacy and Pharmaceutical Sciences and Research Director of the Tenovus Centre for Cancer Research in Cardiff, Wales. He received his BSc in Physiology and Biochemistry at the University of Reading, and his PhD at the University of Wales carrying out “Enzyme studies in experimental breast cancer”.
He has held several positions at the University Of Wales College Of Medicine and the School of Pharmacy and Pharmaceutical Sciences:
- Medical Research Council Postdoctoral Research Fellow, University of Wales College of Medicine (UWCM) 1975-1988;
- Research Officer and Head of Breast Cancer Unit of Tenovus Cancer Research Centre, UWCM 1979-1988;
- Principal Research Officer, Tenovus Cancer Research Centre, UWCM 1989-1997;
- Research Co-ordinator, Tenovus Cancer Research Centre, UWCM 1996;
- Reader, UWCM 1998;
- Personal Chair, UWCM 1999;
- Chair of Cancer Pharmacology, Welsh School of Pharmacy, Cardiff University 2000-to-date;
- Director of Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University 2000-to-date.
- Co-ordinator of Experimental Cancer Therapeutics theme, Welsh School of Pharmacy, Cardiff University 2006-to-date.
His research within the School of Pharmacy and Pharmaceutical Sciences has been directed towards gaining an understanding of, and therapeutically exploiting, the inter-relationships between hormones and the initiation, development and growth of breast cancer. Professor Nicholson is the author of over 300 journal articles and book chapters.
Scientific & Professional Service
Professor Nicholson is currently a member of several clinical trial groups (e.g. ABC Steering Group and Trials Panel and Trial of Perioperative Endocrine Therapy - Individualising Care Steering Group (POETIC)), committees (e.g. Wales Cancer Institute Executive and forum Committees) and he serves on the editorial board of the American Association for Cancer Research and Endocrine Related Cancer.